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Abstract
Objective—To conduct a comprehensive literature review to develop recommendations for
managing obesity among workers to improve health outcomes and to explore the impact of obesity
on health costs to determine if a case can be made for surgical interventions and insurance
coverage.
Methods—We searched PubMed from 2011–2016, and CINAHL, Scopus, and Cochrane
Registry of Clinical Trials for interventions addressing obesity in the workplace.
Results—A total of 1,419 articles were screened, resulting in 275 articles being included. Several
areas were identified that require more research and investigation.

Author Manuscript

Conclusions—Our findings support the use of both lifestyle modification and bariatric surgery
to assist appropriate patients in losing weight.

INTRODUCTION

Author Manuscript

Obesity is a disease commonly defined as a body mass index (BMI) of ≥30 kg/m2. Recent
data from the National Health and Nutrition Examination Survey (NHANES) reports that the
prevalence of obesity among US adults is 37.7%, with more women than men having obesity
(35.0% men v. 40.4% women).1 Diet, lifestyle, and genetics all play a role in the increase of
obesity. However, with the conversion of the American workforce from predominately
manual labor to desk jobs, this has placed more focus on the workplace as a contributor to
the growth of the obesity problem. This decline in manual labor has resulted in a decrease in
more than 100 calories in both men and women in their daily occupation-related energy
expenditure.2 Sitting time at work is associated with higher BMI.3
Increasingly, the responsibility for managing obesity among the working population has
fallen to employers, large and small. However, companies offer different levels of care and
modalities related to weight management which may contribute to access issues for workers.
A recent online survey that measured consumers’ perceptions of medical services covered
by their health insurance, participants reported low prevalence of coverage for a registered
dietitian (28%), bariatric surgery (26%), medications designed to promote weight loss
(24%), and medical weight management (23%). Of those participants who were employed,
“16% indicated that their employer had a wellness program with incentives or penalties
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based on their weight or BMI.” Participants that had access to these wellness programs
reported more coverage for obesity treatment – coverage for a registered dietician (60%),
medical weight management (53%), bariatric surgery (32%), and pharmacotherapy (30%).4
In order to have a healthy company, employers and their health plan designers need to
understand how to manage obesity among their employees and develop evidence-based
programs focused on obesity prevention and treatment, so they could offer the American
worker benefits that can assist with improving their health.

BACKGROUND

Author Manuscript

In order to provide employers with appropriate recommendations on managing obesity
among the working population, the American College of Occupational and Environmental
Medicine (ACOEM) conducted a systematic review of the literature on obesity related to the
workplace. In response, ACOEM convened a 14-member, multi-disciplinary panel
comprised of experts in occupational medicine, internal medicine, pediatrics, emergency
medicine, surgery, advanced laparoscopic and bariatric surgery, obesity medicine, public
health, clinical psychology, and exercise physiology to develop this guidance document that
addresses the management of obesity among workers to improve health outcomes. This
document is also intended to explore the impact of obesity on health costs in order to
determine if a case can be made for lifestyle, non-surgical and surgical interventions and
insurance coverage of such interventions.

METHODOLOGY
Author Manuscript

A Research Team was engaged to conduct a comprehensive literature review. In compiling
available evidence upon which to develop recommendations for managing obesity in the
workplace, the Research Team classified the studies by level (Level 1 – randomized
controlled trial; Level 2 – prospective cohort studies, prospective comparative studies, and
large population-based studies; Level 2a – prospective simulation studies), and summarized
them into evidence tables. The Panel then reviewed the evidence tables and developed
appropriate recommendations based on the available evidence.
Using ACOEM’s Methodology as a guide,5,6 the Research Team searched PubMed from
2011 through 2016 (see supplement materials for search terms), and also CINAHL, Scopus,
and Cochrane Registry of Clinical Trials using similar search criteria. Interventions
addressing obesity in the workplace prior to 2011 have been previously reviewed.7

Author Manuscript

Inclusion criterion were Level 1 (randomized controlled trials) and Level 2 evidence
(prospective cohort studies, prospective comparative studies, and large (n >25,000)
population-representative sampling studies). Prospective studies incorporating simulation as
opposed to empirical data were included, but qualified as Level 2a studies. Articles were
required to be relevant to obesity specifically in the workplace setting to be included. Studies
that measured cognitive performance and behavioral outcomes in a laboratory setting – and
could be considered relevant to the workplace by extrapolation of laboratory settings to
workplace settings – were also recommended by the Panel. However, these were qualified as
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extrapolation rather than direct testing in the workplace. Thus, we applied our standard
evidence classification to these studies, but qualified them as Level 1* or Level 2* (Table 1).
The total number of articles screened was 1,419. The search resulted in 80 Level 1 articles,
187 Level 2 articles, and 8 simulation studies. The number of included articles was 275
(Table 1). See supplemental materials for evidence tables of included studies.

DEFINITIONS
For the purposes of this discussion, overweight is defined as a BMI of 25–29.9 kg/m2 and
obesity defined as a BMI ≥30 kg/m2. This definition is broken down into standard three
classes of obesity – Class I Obesity (low risk) with a BMI of 30–34.9 kg/m2, Class II
Obesity (moderate risk) with a BMI of 35–39.9 kg/m2, and Class III Obesity (high risk) with
a BMI ≥40 kg/m2.8

Author Manuscript

Target Population
The definition of obesity for working, non-Asian adults, age 18–65 years old, employed in
the US, is a body mass index (BMI) of ≥30 kg/m2. For an Asian population, the definition
has been defined by the World Health Organization (WHO) as a BMI ≥27.5 kg/m2.9
Although BMI is widely used in health and productivity population-based research, there are
limitations and controversies associated with its use to determine individual employee risk
for morbidity and mortality.

ASSOCIATION
Author Manuscript

Medical expenditures including pharmaceutical costs, and productivity metrics including
absenteeism, short-term disability (STD), workers’ compensation (WC), and productivity
have all been found to be associated with BMI. The greatest impact is for a worker with a
BMI ≥30 kg/m2. There have been several employee-based studies on the association of BMI
with worker absenteeism, disability, workers’ compensation claims, and on-the-job
productivity or performance also termed “presenteeism,” which refers to working while sick
and, similar to absenteeism, can result in the loss of productivity. These studies have
generally shown a “J-shaped” relationship between BMI and these productivity metrics with
a BMI of approximately 25 kg/m2 at the nadir of the J-shaped curve.

Author Manuscript

For example, a study of 3,066 financial services employees who had completed a health risk
appraisal (HRA) which was linked to the employee’s medical claims (inpatient, outpatient,
prescription drugs) found that for both men and women there was a J-shaped curve with the
greatest medical costs for a BMI ≥30 kg/m2.10 The drivers of these medical claims were
cancer, digestive, circulatory, mental disorders, and musculoskeletal disorders. A study of
35,932 employees and spouses in a manufacturing company who participated in a health
plan and completed an HRA, found that medical and pharmaceutical costs increased
$119.70 (4%) and $82.60 (7%) respectively per BMI unit adjusted for age and gender. For
individuals with diabetes and heart disease, the likelihood of having a medical claim
increased 11.6% and 5.2% respectively for each BMI unit.11 Similarly, a study of 29,699
employees from several employers who had completed a HRA linked to their medical claims

J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 4

Author Manuscript

including pharmaceutical claims also showed a J-curve association with the greatest costs
for employees with a BMI ≥30 kg/m2.12 Another study found that “four of the 10 modifiable
health risks (class I and class III obesity, high blood pressure, high blood glucose, and high
cholesterol) were significantly associated with increased medical care costs when employee
demographics and other health risks were held constant. Class I obesity risk was associated
with higher costs for each outcome.”13

Author Manuscript

Workdays lost to STD and absenteeism have also been shown to have a linear or J-curve
relationship with BMI. A study of more than 17,000 employees in a financial services
company reported that the percentage of workers with an STD event steadily increased with
BMI and the number of workdays lost per STD event was a J-curve with longer durations for
a BMI ≤18.5 kg/m2 and BMI ≥30 kg/m2.14 A more linear association of BMI and the
percentage of workers with an STD was also noted by Burton et al,10 although Van Nuys et
al,12 found an association for both absenteeism and STD.
A study of more than 11,000 health care and university employees reported on a strong
linear association between BMI and WC injuries. The relative risk of a WC claim increased
from 0.81 for a worker with a BMI ≤18.5 kg/m2 to 1.45 for a worker with a BMI of ≥40
kg/m2.15 Van Nuys et al, reported on a J-curve association of BMI and WC claims in almost
30,000 from a multi-employer database with linked WC and HRA data.12 Similarly, Hertz et
al, reported a linear association between work limitation prevalence and BMI using the
National Health Interview Survey 2002 data.16

ASSESSMENT OF OBESITY
Author Manuscript
Author Manuscript

Obesity can be defined as an amount of body fat higher than what is considered healthy for
an individual’s weight.17 The Panel encountered various approaches to determine patient
obesity. BMI is an anthropometric calculation of body weight (kg) divided by height squared
(m2). Current assessment and management guidelines from the US,18 Canada,19 and
Europe20 recommend measuring BMI as a first step in evaluating adult patients for obesity.
The National Committee for Quality Assurance (NCQA) 2017 Healthcare Effectiveness
Data and Information Set (HEDIS) measure for obesity also utilizes BMI as the criterion to
document assessment.21 According to the American Heart Association/American College of
Cardiology/The Obesity Society (AHA/ACC/TOS) 2013 Guidelines for Managing
Overweight and Obesity in Adults,18 it is recommended to measure height and weight and
calculate BMI at annual visits or more frequently depending on the patient’s risk factors.
Furthermore, based on the evidence of assessment and benefits of treatment, the US
Preventive Services Task Force recommends screening all adults for obesity, and that
patients with a BMI of ≥30 kg/m2 receive intensive, multicomponent behavioral
intervention.22 A desirable or healthy BMI is 18.5–24.9 kg/m2, overweight is 25–29.9
kg/m2, and obesity is ≥30 kg/m2. As noted above obesity is further sub-defined into Class I
(30.0–34.9 kg/m2), Class II (35.0–39.9 kg/m2), and Class III (≥40 kg/m2). Corresponding
designations are used by ICD-10 for coding and billing purposes.
Since abdominal fat is an independent contributor to the development of comorbid diseases
such as type 2 diabetes, cardiovascular disease, and metabolic syndrome, proper
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measurement of waist circumference (girth) also is recommended for individuals with BMI
25–34.9 kg/m2 to provide additional information on risk. (Metabolic syndrome is a group of
risk factors that raises risk for heart disease and other health problems, such as diabetes and
stroke. The five metabolic risk factors are: 1) waist circumference ≥35 inches for women,
≥40 inches for men; 2) triglycerides >150 mg/dl (or on medicine to treat); 3) HDL<40 mg/dl
for men and <50 mg/dl for women (or on medicine to treat); 4) blood pressure (BP) >139/89
(or on medicine to treat); and 5) fasting blood sugar 100–126 md/dl (or on medicine to
treat). At least three metabolic risk factors are required for a diagnosis of metabolic
syndrome.23) It is not necessary to measure waist circumference in patients with a BMI ≥35
kg/m2 because waist circumference will likely be elevated and adds no additional risk
information; however, it can be useful for monitoring and education. The AHA/ACC/TOS
Expert Panel recommends using the cutpoints >88 cm [>35 inches] for women and >102 cm
[>40 inches] for men as indicative of increased cardiometabolic risk.18,24 Lower cutpoints
have been suggested for some racial and ethnic groups since the threshold for excessive
abdominal fat and incidence of co-morbid disease appears to vary from Caucasian
populations.25
Staging of Obesity

Author Manuscript
Author Manuscript

Efforts are underway to develop more practical and useful assessments to identify patients
who require more intense intervention. Analogous to other staging systems commonly used
for congestive heart failure or chronic kidney disease, a cardiometabolic disease staging
system (CMDS) was developed that assigns patients to one of five risk categories using
quantitative parameters readily available to the clinician,26 without regard to BMI. With
advancement from stage 0 to stage 4, there are significant increments in risk and adjusted
HR for diabetes, all-cause and cardiovascular disease (CVD)-related mortality. A refinement
of the staging system was incorporated in the recently released Clinical Practice Guidelines
for Comprehensive Care of Patients with Obesity issued by the American Society of Clinical
Endocrinologists (AACE) and American College of Endocrinology (ACE).27 Using this
guideline, obesity disease stage is based on ethnic-specific BMI cutoffs along with
assessment for adiposity-related complications. Stage 0 is assigned to individuals who are
overweight or those who are obese by BMI classification but have no complications,
whereas Stage 1 and 2 are defined as individuals who are overweight or those who are obese
by BMI classification and having 1 or more mild-moderate complications (Stage 1) or at
least 1 severe complication (Stage 2). The AACE guidelines explicitly recommend using a
complication-centric assessment, whereby the presence of obesity comorbidities (such as
cardiovascular disease), in addition to anthropometric measures (such as BMI), guides
treatment indication, intensification, and goals, with the intent of targeting the most
aggressive treatments to those who might derive highest benefit.
A different functional staging system for obesity that is independent of BMI, called the
Edmonton Obesity Staging System (EOSS), uses a risk-stratification construct.28 Using this
approach, individuals with obesity are classified into 5 graded categories, based on their
morbidity and health-risk profile along three domains – medical, functional, and mental. The
staging system was recently shown to predict increased mortality among two large
population cohorts.29,30
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IMPACT
Health & Safety
Obesity is associated with numerous health and safety risks. Health risks include prediabetes mellitus, diabetes mellitus, coronary heart disease, depression, hypertension, high
cholesterol, sleep apnea and respiratory problems, stroke, gallbladder disease, osteoarthritis,
some cancers31 (endometrial, breast, colon, kidney, esophagus, gallbladder, pancreas, and
liver), and metabolic syndrome. In addition to health risks, health care and disability costs
associated with obesity are also increased. Individuals are not working as long as they could
because of the premature disability associated with being obese. One study found that as
BMI increases from 30 to 35, the probability of a short-term disability claim increases 25%
(from 3.6% to 4.5%) for those without hypertension, hyperlipidemia, or diabetes and 37%
(4.9% to 6.7%) for those with one of these comorbidities.12

Author Manuscript
Author Manuscript

In 2013, the American Medical Association classified obesity as a “multi-metabolic and
hormonal disease state” that leads to unfavorable outcomes.” Obesity is associated with
lower levels of productivity, decreased quality of life, and increased mortality.32 People with
obesity, as compared to those of a healthy weight are at increased risk for many serious
diseases and health conditions affecting multiple organ systems.33–35 “Recent data provides
strong evidence for a causal role of higher BMI and risk of type 2 diabetes and hypertension,
and evidence that BMI increases risk of coronary heart disease.”36 Obesity is associated
with an increase in CVD such as coronary artery disease and stroke as well as CVD risk
factors such as hypertension and dyslipidemia. Obesity is also associated with prediabetes
(when the blood glucose level is higher than normal) and type 2 diabetes. Both prediabetes
and diabetes are also risk factors for CVD. The term “metabolic syndrome” is used to
combine many of these cardiovascular risk factors under one umbrella. Obesity may be a
risk factor for musculoskeletal disorders such as osteoarthritis, back pain, and increased
difficulty with physical functioning,37 and is a major cause of knee replacement surgery.33 A
recent study using 17 years of data from 38,214 university and health system employees
reported a significant interaction between BMI and musculoskeletal (MSK) injury risk. The
effect of BMI was strongest for ‘low’ MSK injury risk occupations, but the absolute MSK
injury rates for ‘mid’/‘high’ MSK injury risk occupations remained larger.38

Author Manuscript

In addition, the respiratory system may be affected by obesity. Obstructive sleep apnea
(OSA) and obesity hypo-ventilation syndrome (OHS) are commonly seen in persons with
obesity.39,40 There is also a bi-directional relationship between sleep disorders and obesity.
A 2010 review found that 90% of patients with OHS have coexistent OSA and the remainder
have sleep-related hypoventilation.41 “Among patients with OSA, the prevalence in the U.S.
of OHS is approximately 6%, 18% and 25% for those having a BMI 30–34, 35–39, and
equal to or greater than 40, respectively.”41 Obesity may be associated with gastrointestinal
system conditions such as gallbladder disease, gastroesophageal reflux disease (GERD), and
non- alcoholic fatty liver disease. Obesity related genitourinary system conditions include
urinary incontinence due to weakened pelvic muscles and abnormal ovulation.42
Obesity also is associated with a significant psychosocial burden. Excess body weight is
linked to decreased quality of life as well as increased depressive symptoms and higher rates
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of mood disorders. Individuals with obesity are often stigmatized and discriminated against
in a wide range of social situations, including the work place. Persons with obesity are hired
less frequently than those of average body weight, receive lower salaries and less frequent
promotions, and report less satisfaction with their employment than individuals of average
body weight.43
Studies have also found an indirect association between excess body weight and workplace
safety.40 Rates of workers’ compensation claims were twice as high, medical claims costs 7
times higher, and indemnity claim costs 11 times higher among the heaviest employees vs
employees of average weight.15 Compared to normal-weight employees, those with a higher
BMI requested more workers’ compensation days: 2.92 vs 8.59.12
Economic Burden

Author Manuscript

Obesity among workers has adverse occupation-related consequences (work absence,
impairment, limitation, and workplace injury) and increased health care and disability costs.
Between a BMI of 25 and 45 kg/m2, medical and drug costs increased $119.7 and $82.6 per
BMI unit increase adjusted for age and gender.11 Estimated mean annual per capita health
care expenses attributable to obesity are $1160 for men and $1525 for women.44 Workers
who were obese had more than double the work limitation of those who were of normal
weight.16

Author Manuscript

Obesity is associated with a significant increase in absenteeism among US workers, which
costs the nation an estimated $8.65 billion per year, accounting for 6.5% to 12.6% of total
costs of absenteeism in the workplace.45 Obesity associated with increase in workdays
absent; ie, 1.1 to 1.7 extra days missed annually compared with normal-weight employees.45
Compared to normal weight employees, those with higher BMI showed a trend for increased
health care spending. In 2011, dollars out-of-pocket spending rose from $371.32 to $632.53,
and total medical costs increased from $3863.34 to $7924.53. Similarly sick days were 5.29
and 7.43, and short-term disability days were 1.94 and 4.77 in comparison.12

PROBLEM OF OBESITY IN THE WORKPLACE
In the US, nearly 38% of adults have obesity. Obesity is more common in women (40.4%)
than men (35%), and rates have exceeded 35% prevalence in four states, 30% in 25 states,
and 20% in all other states.1,46 One forecast estimates a 33% increase in obesity and a 130%
increase in severe obesity (BMI >40 kg/m2) by 2030.47

Author Manuscript

Rates of obesity differ by race and ethnicity. Blacks (48.4%) and Latinos (42.6%) have
higher obesity rates than Whites (36.4%) and Asian Americans (12.6%).1 In addition, there
are inequities in obesity among different education and/or income levels and among different
occupations. According to the 2008–2010 Behavioral Risk Factor Surveillance Survey,
32.8% of adults who did not graduate high school had obesity vs 21.5% of those who
graduated from college/technical school. Nearly 34% of adults who earn less than $15,000
per year have obesity compared to 24.6% of adults whose income is above $50,000.48
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With an increase of US employees who are overweight or have obesity, a number of studies
have measured the impact on employer health care expenditures. Additionally, researchers
have demonstrated the association of BMI with absenteeism and presenteeism, as well as
WC costs related to injuries and illnesses.
Andreyeva et al, utilized the National Health and Nutrition Survey (NHANES) database of
the US civilian, non-institutionalized population to study obesity and absenteeism. Obesity
attributed absenteeism among American workers cost the nation an estimated $8.65 billion
per year in 2012.45 The authors reported that obesity was associated with a significant
increase in lost workdays, from 1.1 to 1.7 extra days missed annually when compared to
normal weight employees. Interestingly, obesity was found to account for 6.5–12.6% of total
costs of absenteeism in the workplace, with results almost identical to the data on obesity in
health care expenditures.

Author Manuscript

Van Nuys et al, reported a J-shaped association with BMI and a variety of metrics including
health care expenditures, sick days, workers’ compensation, and STD absences. They
studied 29,699 employees from a variety of employers who had health risk appraisal (HRA)
data linked to their health claims and productivity data. Normal-weight employees cost an
average of $3,830 per year in combined medical, sick days, STD, and WC claims while
employees with a BMI >40 kg/m2 cost more than double that amount ($8,067) in 2011
dollars.12 The nadir of health care costs and lost productivity was associated with a BMI of
25 kg/m2.

Author Manuscript

In looking at a Total Worker Health® model, (defined as policies, programs, and practices
that integrate protection from work-related safety and health hazards with promotion of
injury and illness prevention efforts to advance worker well-being) Dong et al, studied
occupational and non-occupational factors associated with work-related injuries among
12,686 US construction and non-construction workers in the National Longitudinal Survey
of Youth. Obese/overweight, smoking, and cocaine use were risk factors for work-related
injuries when demographics and occupational factors were held constant.49

Author Manuscript

Overweight and obesity have also been associated with lost on the job productivity. A study
based on the National Health Interview Survey 2002, found that the 9,636 workers with
obesity had more than double the work limitation of workers who were normal weight.16
Workers with obesity were found to have a 6.9% prevalence of work limitations vs 3.0%
among normal-weight workers. Bustillo et al, reported on 56,971 respondents to the 2009–
2010 Canadian Community Health Survey and found that obesity is marginally associated
with absenteeism and presenteeism.50 BMI has been found to be associated with a number
of other medical conditions among workers including emotional exhaustion,51 menopausal
vasomotor symptoms,52 and diabetes-related metabolic risk factors in workers in China.53
With rising levels of obesity among workers, employers are evaluating the impact of
increasing weight not only on health care costs, but occupational injuries, absenteeism,
presenteeism and thus, prompting a focus on workplace interventions to address this public
health issue.
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IMPACT OF THE WORKPLACE ON OBESITY
Obesity is highly contextual—obesity may be considered a consequence of the reciprocal
manner in which individuals interact with their environments.54 The workplace environment
represents an important consideration because of the reciprocal nature between obesity and
employment. While many researchers studied the impact of obesity on performance and
productivity, it is equally important to note the potential influence of work on obesity.
Work as a Causal Factor for Obesity

Author Manuscript

Work has previously been recognized as a source of adverse environmental exposures
associated with obesity (or excess weight gain).2,55–58 Activities to consider in conceptual
frameworks include multi-level influences (ie, individual, group, organization, and
community level), corporate vision (eg, leadership, cultural norms and values, and worker
involvement), and environmental approaches including conditions of work (eg, physical
environment, psychosocial factors, socioeconomic environment, and job tasks and
demands).58,59 Risk factors that have been associated with obesity among workers include
social stressors, psychosocial work factors, working hours, sleep and night shift work, and
sedentary behavior.
Social Stressors

Author Manuscript
Author Manuscript

Work-related stress includes conflicts with co-workers and supervisors, a lack of control of
work functions, and a negative group climate at work. Kottwitz et al, studied the influence of
social stress among women workers on BMI and change in BMI over the course of a year.
Measures of social stress in the workplace – including job control and conflict with coworkers – were found to positively correlate with BMI.60 Furthermore, the authors noted
that increased social stressors at work and reductions in job control increased BMI
longitudinally. Low decision latitude, defined as the lack of authority to make important
decisions, was also associated with obesity in a study by Nelson et al.61 Being harassed
while at work, including being sworn at, screamed at, and receiving hostile or offensive
gestures, was associated with both obesity and low levels of physical activity.61,62 Similarly,
physical threats at work were noted to be moderately associated with weight gain in a
longitudinal cohort study in Finland.56 In a study designed to test the association between
lifestyle-related modifiable health risks (physical activity, cardio-respiratory fitness, and
obesity), Pronk et al, observed that severe obesity (BMI ≥40 kg/m2) was associated with an
increased number of work loss days, but obesity (BMI ≥30 kg/m2 and ≤40 kg/m2) was
related to an increased difficulty of getting along with coworkers.63 In a 14-year longitudinal
study of Canadian workers, decision authority was noted to be a significant work-related
predictor for obesity among women, but not men.64
Psychosocial Work Factors
Psychosocial work factors, such as job demands, job content, job control, social interactions,
and job future and career issues,65 may affect health and well-being. Health behaviors may
be intermediate factors between the psychosocial work environment and health-related
outcomes, such as obesity or excessive weight gain. Quist et al, followed Danish health care
workers (3,982 men/152 women) as part of a cohort study with 3 years of follow-up and
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studied psychosocial work environmental factors and weight change.66 Specifically, they
looked at work pace, workload, quality of leadership, influence at work, meaning of work,
predictability, commitment, role clarity, and role conflict. High-quality leadership predicted
weight loss among men. Among women, high role conflict and living alone predicted weight
gain whereas high role clarity predicted both weight gain and weight loss. Another
longitudinal cohort study conducted in Finland by Roos et al, noted that during the 5- to 7year follow-up (during which time 26% of women and 24% of men gained 5 kg or more),
physical threats at work were modestly associated with weight gain.56

Author Manuscript

Social interactions may be a strong influence in the workplace where individuals spend a
large share of their waking hours.32,67,68 Obesity proves to have myriad causes and
associations. Diet, calorie expenditure, diabetes, stress, and quality and quantity of sleep all
appear clustered around obesity.68–70 Workers with obesity are over-represented vs the
general population in certain occupations.32,70,71 For example, one study found that nonHispanic white males who worked in health care support (36.3%), protective service
(34.3%), and transportation and material moving (33.7%) had the highest prevalence of
obesity while among non-Hispanic white female workers, the highest prevalence of obesity
was in farming/fishing/forestry (35.9%), transportation and material moving (31.5%), and
production (30.4%).32

Author Manuscript

A factor that is certain to cut across all jobs is the social network that underpins the
employment milieu. Obesity in a first degree friend carries a 45% higher rate of obesity for
the individual.67 Same sex contacts with obesity increases the individual's chances for
obesity by 71%.67 There is likely a large component of altered social norms contributed to
the obesity “contagion.”32,67 If an individual deems someone with obesity a friend (one
sided), there appears to be a 57% increase in obesity risk. If the regard is mutual then the
number rises to 171%.67 Clearly, social distance and strength of the social bond contribute
greatly to the spread of obesity in the social context.
Although there are positive impacts to measures such as voluntarily increasing activity at the
workplace,32 further research on the social factors within the workplace may provide further
insights and mitigation strategies to the growth of the obesity problem. By understanding
some of the organizational and psychosocial factors of these jobs, more targeted and perhaps
more effective interventions can be brought to bear.
Working Hours

Author Manuscript

Based on data from the 2010 National Health Interview Survey, employment involving work
of more than 40 hours per week and exposure to a hostile work environment were associated
with obesity.66 Similar results were noted for older workers based on panel data from the
Health and Retirement Study.72 Here, older employees who worked more than 59 hours per
week were 23% more likely to gain weight as compared to those who worked less than 59
hours per week. Hauck and Hollingsworth reported that employment itself is associated with
more weight gain and less weight loss among middle-aged women.73 Furthermore, they
noted that among employed women, increasingly long working hours were associated with
more weight gain, especially higher levels of weight gain.
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Sleep problems and obesity appear to cluster among working men and women in the same
work unit, as reported by Oksanen et al, in a large study of 39,873 workers from 3,040
workplaces in Finland.40 Given the co-occurrence of sleep problems and obesity among
workers in the same work unit, interventions to reduce sleep and obesity problems may
benefit from identification of “risky” workplaces. Night work has previously been associated
with negative health effects. Buchvold et al, found a significant positive correlation between
the number of night shifts worked in the last year and BMI.74 In contrast, Bekkers et al, did
not report a positive association of night and shift work with weight change over 1 year,
although they did note a larger weight increase among normal weight workers who went
from day to shift work.75 Night shift workers often have lack of choices to healthy meals due
to poor access to healthy foods at night and this may be one reason for a correlation between
poorer sleep patterns and eating behaviors.76 In general, despite some inconsistencies, a
recent review of the literature concludes that there seems to be convincing evidence that shift
work increases the risk of obesity.77
Sedentary Behavior

Author Manuscript

Increased sedentary behavior is associated with obesity. Fixed night work has been
associated with lower likelihood of becoming physically active.78 Based on a 2-year followup study with a cohort of 2,062 recently graduated female health care assistants, the
researchers reported no significant relationships between fixed night work with weight gain
or obesity. Church et al, studied occupational physical activity and energy expenditure trends
over the past 5 decades for US workers and the relationships to obesity noting that during
the 50 years between 1960 and 2010, daily occupation-related energy expenditure has
decreased by more than 100 calories.2 This reduction expressed in energy expenditure
accounts for a significant portion (≥80%) of the increase in mean US body weight for both
men and women during the same timeframe. Based on a review of the literature, Shrestha et
al, concluded that no significant association is yet shown between sedentary work and
obesity, noting that simply replacing sitting at work by standing at work is unlikely to
prevent or manage obesity.77

BENEFITS OF ADDRESSING OBESITY IN THE WORKPLACE

Author Manuscript

The US Centers for Disease Control and Prevention (CDC) recommends four main
evaluation measures for determining the benefits of interventions addressing obesity in the
workplace: 1) worker productivity, 2) health care cost, 3) health outcomes (obesity and
related conditions like hypertension and type 2 diabetes), and 4) organizational change
(health behaviors).79
Worker productivity is most easily measured as absenteeism. Van Wormer et al, assessed 2year absenteeism among 1,228 employees completing a worksite-randomized trial that
evaluated an environmental weight gain prevention intervention.80 They found weight
change and baseline weight interacted to influence absenteeism – employees who were
obese and gained weight averaged 6.6 sick days over 2 years vs. normal-weight employees
who maintained weight who averaged less than half this number. These results suggest that
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addressing obesity in the workplace, particularly through the prevention of weight gain, can
benefit productivity by reducing absenteeism.
However, CDC notes that while worker productivity can be measured by number of sick
days, a more precise indication can be gained by the use of a questionnaire such as, the
Health and Work Performance Questionnaire (HPQ), a 10-point instrument assessing
absenteeism and presenteeism. Harden et al, administered the HPQ before and after a 12month Internet-delivered weight-loss intervention among 1,030 workers with a BMI of >25
kg/m2.81 Although 22% of the participants achieved clinically meaningful weight loss (>5%
initial weight), no statistically significant changes in HPQ presenteeism or absenteeism were
observed.

Author Manuscript

Future research is required to better define whether addressing obesity in the workplace can
improve worker productivity and contain health care costs, and whether such efforts should
target weight gain prevention as opposed to weight loss. Studies must also incorporate
measures of presenteeism which has been studied less extensively than absenteeism. A prior
systematic review identified 14 studies addressing the influence of workplace health
promotion programs on presenteeism, finding approximately half of them yielded improved
presenteeism but substantial discrepancies regarding the best intervention strategies to
promote presenteeism as well as methods to assess presenteeism.82

MANAGEMENT OF OBESITY: NON-SURGICAL INTERVENTIONS
Lifestyle Modification Interventions

Author Manuscript

A program of diet, physical activity, and behavior therapy (ie, lifestyle modification) has
long been the cornerstone of treatment for most individuals with obesity. A 5% weight loss
is considered clinically significant.18(18) In trials conducted in academic medical centers,
persons counseled to eat a diet of 1200–1500 kcal/d, combined with regular exercise and a
comprehensive program of lifestyle modification, lost approximately 7–10% of their initial
weight in approximately 6 months.83,84

Author Manuscript

These interventions have been modified for use in primary care practice,85,86 as well as
specialty medical practices, such as infertility programs.87 Weight losses and improvements
in weight-related comorbidities seen in these studies have been clinically significant for the
majority of treated patients, but often not as robust as seen in well-controlled efficacy
studies. In recent years, investigators have modified these interventions for administration
using telephone-based counseling, internet sites, and smart phone applications.88 Similar to
studies conducted in medical settings, weight losses with these approaches are typically
more modest than those seen in studies that involve direct patient-provider contact.
This literature has served as the foundation of lifestyle modification interventions delivered
in the workplace. A large number of studies have investigated lifestyle modification for
weight loss — caloric restriction, increased activity and/or behavioral counseling or support
— offered to employees. Some of these studies have involved the use of commercial
providers brought into the workplace; others have used a self-help or peer-support model.
Other programs have focused on specific aspects of lifestyle modification — changing the
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food available in cafeterias through a number of strategies, promoting physical activity with
increased walking, or organizing employees to work together as teams and compete with one
another. The wide creative range of approaches likely has helped foster levels of employee
engagement, but also makes cross-study comparisons difficult. In general, lifestyle
modification interventions delivered in the workplace produce modest, but often clinically
significant weight losses and improvements in weight-related health problems for many
individuals (see evidence tables). However, and is often seen in the high-quality clinical
trials from academic medical centers, sustained engagement in the behaviors that promote
weight loss is difficult and successful weight maintenance in the years after treatment is
atypical. In contrast, the CDC-recognized lifestyle change programs for prediabetes, which
is commonly associated with obesity, showed that those with prediabetes who take part in a
structured lifestyle change program can reduce their risk of developing Type 2 diabetes by
58% (71% for people >60 years old), and the impact of this program can last for years to
come.89
Pharmacotherapy
According to the US Food and Drug Administration (FDA), adjuvant pharmacological
treatments are approved for patients with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 who
also have concomitant obesity-related risk factors or diseases and for whom dietary and
physical activity therapy has not been successful. When prescribing an anti-obesity
medication, patients should be actively engaged in a lifestyle modification program that
provides the strategies and skills needed to effectively use the medication. As with all
medical interventions, the benefits of treatment must out way the risks in terms of side
effects and cost.

Author Manuscript

The Endocrine Society recently published guidelines on the Pharmacological Management
of Obesity.90 Core recommendations include the following:

Author Manuscript

•

Prescribe pharmacotherapy for obesity as an adjunct to diet, exercise and
behavior modification for individuals with BMI ≥30 kg/m2 or >27 kg/m2 with at
least one comorbidity; who are unable to lose and successfully maintain weight;
and who meet label indications.

•

Continue pharmacotherapy if the patient has lost at least 5% of initial body
weight within 3 months of use; if not, discontinue and seek alternative
approaches.

•

In patients with uncontrolled hypertension and/or history of cardiovascular
disease, do not use sympathomimetic agents.

•

Use a shared decision making process in selecting medications, providing
patients with estimates of weight effects of medications.

Since 2012, four new anti-obesity medications were approved by the FDA for weight loss
and maintenance of weight loss: lorcaserin, phentermine/topiramate (PHEN/TPM) extended
release, naltrexone sustained release (SR)/bupropion SR, and liraglutide. Although none of
these medications have been selectively studied in the workplace, reduction of weight and
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associated co-morbid conditions might lead to reduced absenteeism, presenteeism, and
health care expenditures.

Author Manuscript

All of the 4 new medications have undergone randomized, placebo-controlled, double-blind
trials of efficacy and safety. For FDA approval, medications are required to meet at least one
of the following two criteria: 1) the difference in mean weight loss between the activeproduct and placebo-treated groups is ≥5% and the difference is statistically significant;
and/or 2) the proportion of subjects who lose ≥5% of baseline body weight in the activeproduct group is at least 35%, is approximately double the proportion in the placebo-treated
group, and the difference between groups is statistically significant.91 Although weight loss
outcomes vary among the medications, 1-year categorical 5% weight loss ranges from 47.2–
66.7% among those randomized to medication compared to 17.1–27.1% for those taking
placebo. Clinical and statistical dose-dependent improvements were also seen in selected
cardiovascular and metabolic outcome measurements that were related to the weight loss.

MANAGEMENT OF OBESITY: SURGICAL INTERVENTIONS

Author Manuscript

Bariatric surgery is one option for the treatment of obesity. The indications for surgery are
based on a National Institutes of Health (NIH) consensus statement published in 1991 – well
before important advances in bariatric surgery (namely accreditation), widespread use of
laparoscopy, and increased understanding of obesity. These indications include a BMI of
≥40 kg/m2 or ≥35 kg/m2 with comorbidity, as well as documentation of previous weight loss
efforts and absence of psychiatric or medical contra-indication. The most commonly
performed procedures in the US include gastric bypass and sleeve gastrectomy followed
distantly by lap band and duodenal switch. Each procedure has its own advantages and
potential risks. On average, patients tend to lose two-thirds of their excess body weight 1
year after surgery and maintain substantial weight loss long term.92–94
Recent data, as well as improved outcomes, have led many experts and medical societies to
suggest modifying the indications for bariatric or metabolic surgery. An international
consensus of diabetes experts recently published guidelines using multiple randomized
controlled trials with data now extending to 5 years. The data that found surgical therapy for
type 2 diabetes results in superior outcomes to maximal medical therapy. Forty-five medical
societies now recommend bariatric surgery for any individual with a BMI >35 kg/m2 and
type 2 diabetes. Furthermore, these guidelines recommend that surgery be considered for
type 2 diabetics with a BMI of 30–35 kg/m2 who are not optimally controlled by medical
therapy.95

Author Manuscript

Bariatric surgery has been shown in appropriate patients to be the most effective method for
weight loss and prevention of recidivism. There are multiple procedures offered and weight
loss for procedures, such as gastric bypass and vertical sleeve gastrectomy, generally result
in excess weight loss of greater than 60%.With higher BMIs, lower percentages are seen on
average. Perhaps, more importantly, obesity-related comorbid conditions can improve or
even go into remission. In addition to diabetes, sleep apnea, hypertension, hyperlipidemia,
degenerative joint disease, polycystic ovary syndrome, pseudotumor cerebri, chronic venous
insufficiency, and gastroesophageal reflux disease have been shown to improve or resolve
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following bariatric/metabolic surgery.96 However, surgery is invasive and complications can
occur. Long-term effects reported in the literature have included rise in alcohol misuse,
suicide, overdose and accidental death, preferential loss of lean mass, loss of bone and
muscle, etc., among others including those related to surgery such as wound infections, etc.
97 Laparoscopic gastric band surgery has been associated with significant complications and
is no longer recommended.98 However, in certified centers, the risks of primary bariatric
procedures has been reported to be identical to gallbladder surgery and joint replacement.99
Gastric Bypass

Author Manuscript

Severe obesity is associated with some degree of cognitive impairment which appears to
improve for the majority of patients after the substantial weight loss seen with surgery. A
number of small non-randomized or controlled studies that addressed the association
between gastric bypass and cognitive function found that bariatric surgery has been
associated with improved cognition and possibly reduced the risk of cognitive decline or led
to improvements in cognition.100–104 Several reports that looked at various aspects of
cognitive function are from the Longitudinal Assessment of Bariatric Surgery (LABS)
project,105 a NIH-funded consortium of 6 clinical centers and a data coordinating center that
addressed clinical, epidemiological, and behavioral research in 4,776 patients undergoing
bariatric surgery.

Author Manuscript

Studies of small subsets of LABS patients have addressed mild cognitive impairment (MCI)
and changes 12 months post gastric bypass,106 and the effect of a family history of
Alzheimer’s disease (AD) on cognitive function of attention, executive function, memory,
and language 12 weeks after bariatric surgery.107 These studies found an improvement in
cognitive function following bariatric surgery; however, patients with a reported family
history of AD exhibited a higher prevalence of cognitive impairment and did not show postoperative gains in memory abilities.”107

Author Manuscript

LABS data was also used to evaluate a group of 68 patients with a history of binge eating
disorder (BED) with 20 patients with no history of BED to see if the disorder was associated
with less improvement in neurocognitive functioning test scores 12 months following
bariatric surgery. As hypothesized, participants as a whole displayed significant
improvements in test performance from pre-surgery baseline to post-surgery follow-up
across three of four cognitive domains: attention, executive function, and memory;
improvements were not seen in the domain of language. However, in contrast to
expectations, BED and non-BED groups did not significantly differ in their respective
degree of improvements over time.108 In a recent study of patients with severe obesity, the
surgery group (Roux-en-Y gastric bypass) “had higher remission rates and lower incidence
rates of hypertension and dyslipidemia than did nonsurgery group 1 (P<0.05 for all
comparisons).”109 In addition, “among the patients in the surgery group who had type 2
diabetes at baseline, type 2 diabetes remitted in 66 of 88 patients (75%) at 2 years, in 54 of
87 patients (62%) at 6 years, and in 43 of 84 patients (51%) at 12 years.”109
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Bariatric surgery has also been evaluated to assess its impact on health care expenditures.
Mullen et al. evaluated a prospective cohort of patients undergoing gastric bypass (n = 224)
in a specified health plan over an 85-month period to analyze whether there were cost
savings in terms of less-used health care. The authors utilized a closed, experience network
of surgeons and performed a comparison between actual cost of surgical patients and
projected health plan costs for those who were overweight and obese. In Year 1 post-surgery,
costs for patients were lower than cost the year prior to surgery. By Year 2, surgical patients
had incurred fewer costs than the health plan population with obesity. By Year 3, surgical
patients had incurred fewer costs than the overweight population. By 3.5 years, patients
broke even on surgical costs. The authors concluded that although gastric bypass is a costly
surgical procedure, longitudinal costs savings and overall health improvement for those
undergoing the procedure are cost-effective within a closed, experienced network. Weightloss surgery decreased annual costs per patient in the years after surgery.110
Gastric banding has declined over the past 5 years due to the rise in sleeve gastrectomy,
realization of the heterogeneity of weight loss for gastric banding, and a significant
incidence of surgical complications. Finkelstein initially presented a cost-benefit study of
gastric banding that demonstrated a 5 year cost savings of $10,960, and a return of
investment by the 9th quarter following the procedure. By utilizing indirect costs, net
savings by Year 5 was $34,160. Indirect cost savings were generated by quantifying medical
expenditures, absenteeism and presenteeism rates.111
Other Bariatric Surgery Studies

Author Manuscript

Seven studies related to multiple bariatric procedures were reviewed.104,112–117 A
population-based study of the impact of bariatric surgery on a region of Texas looked at the
burden of obesity on this area and then calculated the benefit of bariatric surgery. Burden of
disease was quantified by loses in business output, employment, income, indirect business
taxes, and days of work. Following surgery, the median and mean of 33 (+/−10) days of
work lost decreased to a median of 0 and mean of 1 (+/−4) days of work lost at 1 year. These
data were derived from patient surveys before and after surgery and extrapolated to the
population. Net benefit of surgery at 3%, 5%, 10% discount rates was $9.9 billion, $5
billion, and $1.3 billion, respectively, to the region, demonstrating that bariatric surgery was
associated with a decrease in lost work days.112 As in numerous other studies, bariatric
surgery is associated with substantial improvements in quality of life, improvements in
mobility, and reductions in self-reported pain.115–118

Author Manuscript

Emerging Invasive Therapies
Based on the success of bariatric surgery, new modalities have been in development to
provide weight loss through endoscopy. Within the last two years, several intra-gastric
balloons have been approved for commercial usage in the US. Balloons – inserted through
the mouth and inflated in the stomach – are left in place for 6 months and then removed via
another endoscopic procedure. As compared to placebo, balloons have been shown to result
in significant weight loss at 6 and 12 months. However, a recent study reported on the deaths
of five patients who underwent intragastric balloon surgery, although the root cause of death
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is at this time unknown.119 Following balloon extraction, there may be a tendency for weight
regain. To date, there are no evidence-based research studies that show an impact on worker
health or productivity. Newer balloon models that can be swallowed and degrade – thus not
requiring extraction – will soon be coming to market.
Another approach uses a pacemaker type device to provide current to the vagus nerve,
blocking certain aspects of vagus nerve propagation. Approved by the FDA for use in 2015,
weight loss is far less than stapling procedures and adjustable bands. Presently, there are no
data documenting an impact on workers afflicted with obesity.
Body Contouring Surgery

Author Manuscript

As a consequence of surgery, body contouring procedures to remove excess skin loss
associated with massive surgical or non-surgical weight loss is often necessary. The
American Society of Plastic Surgeons, reports that more than 50,000 individuals underwent
this procedure to remove excess skin associated with increased body image issues and
decreased physical function and quality of life, which likely motivates pursuit of these
surgical treatments.120,121 The majority of patients who undergo these procedures report
satisfaction with the results and improvements in physical and psychosocial health.
Additional research is required to determine indications for body contouring surgery and
coverage by health insurance.

DISCUSSION
Recommendations for Addressing Obesity in the Workplace

Author Manuscript

Based on this systematic review of the literature regarding worker obesity, it was the
consensus of the Panel that employers should adhere to the following basic
recommendations in an effort to prevent and treat obesity in their workplace.
Prevention—

Author Manuscript

•

Offer appealing, healthy choices in cafeteria and/or vending machines

•

Provide healthier food at meetings and other employee events

•

Ensure access to safe walking areas for employees/encourage employees to use
the stairways

•

Offer wellness classes on nutrition, exercise, and weight management

•

Offer memberships or discounts to health/fitness clubs

•

Offer regular health screenings/Health Risk Appraisals for employees

Treatment—
•

Implement a workplace wellness program that provides opportunities to aid
employees in adopting healthy lifestyles

•

Offer behavioral counseling to employees
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Offer coverage/access to bariatric surgery to individuals with a BMI ≥40 kg/m2,
for those with BMI >35 kg/m2 with significant comorbid conditions associated
with obesity such as type 2 diabetes, hypertension, sleep apnea, infertility,
pseudotumor cerebrei, and those with disabling joint disease requiring surgical
replacement, and individuals with a BMI of 30–35 kg/m2 with type 2 diabetes
who are not optimally controlled by medical therapy27,95

Research Gaps
Panel members identified several areas that require more evidence-based research and
investigation. These include:

Author Manuscript
Author Manuscript

•

The impact of medications on performance and functional outcomes. Use of
medications on a longer-term basis should be investigated, but there are no
studies addressing pharmacological treatment of obesity in the workplace. In
pharmaco-economics, there is an increasing emphasis on including the impact on
productivity in the analysis of a drug’s benefit and in many cases, even included
in the pricing. The lack of pharmacology studies in the workplace is notable and
needs to be addressed.

•

Criteria that includes a supervised diet for 6 months prior to bariatric surgery, as
there is inconclusive evidence regarding the relationship between insurancemandated medical-weight management prior to bariatric surgery and postoperative outcomes.118

•

Identifying post-operative therapies that can be utilized to prevent recidivism.

•

The impact of bariatric surgery on cognitive functioning. As high-level cognition
is a necessary element for safety and productivity, it is important to further
evaluate the association of bariatric surgery and cognitive function. Small non
randomized or controlled studies have shown an association of cognitive function
improvement after surgery; however, further research is needed.

CONCLUSION

Author Manuscript

Helping prevent employees from developing obesity should be an important focus of
workplace-based programs. Insurance companies may need to evaluate their approaches to
coverage accordingly. Prevention is key as noted from two long-term cohort studies which
found that “weight gain from early to middle adulthood was associated with increased risk
of morbidity and mortality, and decreased odds of achieving the composite healthy aging
outcome among women and men…weight gain as little as 5 kg was associated with
significantly elevated incidence of a composite measure of major chronic diseases,
consisting of type 2 diabetes, cardiovascular disease, cancer, and nontraumatic death.”122
The costs of obesity among workers is immense and the responsibility for managing it is
increasingly falling to employers. Employers and their health plan designers need to
understand how to manage and treat obesity among employees in addition to developing
programs that focus on prevention. Employers need to understand that the workplace
environment and employment conditions may contribute to the obesity within a workforce
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and that all efforts to encourage physical activity and eating healthy should be exhausted to
prevent obesity and slow weight gain for all employees. Of the studies that met our inclusion
criteria, many of the findings support both the use of lifestyle modification leveraging the
workplace social context and the use of bariatric surgery in appropriate patients and in
certified centers to assist patients in losing weight. As these interventions may prove cost
effective in the long term, a case can be made that they be covered by insurance. The intent
of this document is to help guide future research in the realm of obesity among workers.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.

Acknowledgments
Author Manuscript

ACOEM and the members of the Panel wish to thank Pamela Allweiss, MD, MPH, for her contributions as a
reviewer to this document.
DISCLOSURES
Support for this project is through funding from Covidien LP, a subsidiary of Medtronic plc. In addition, NIH/
NIDDK (T32DK097718) supported Garrett I. Ash, MSc, PhD, to perform research and writing for this project.

References

Author Manuscript
Author Manuscript

1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults
in the United States, 2005 to 2014. JAMA. 2016; 315(21):2284–91. [PubMed: 27272580]
2. Church TS, Thomas DM, Tudor-Locke C, et al. Trends over 5 decades in U.S. occupation-related
physical activity and their associations with obesity. PLoS One. 2011; 6(5):e19657. [PubMed:
21647427]
3. Lin TC, Courtney TK, Lombardi DA, Verma SK. Association between sedentary work and BMI in a
U.S. National Longitudinal Survey. Am J Prev Med. 2015; 49(6):e117–23. [PubMed: 26437869]
4. Kyle, T., Nadglowski, J., Stanford, F. Consumers Report That Health Insurance Does Not Often
Cover Obesity Treatment, Even When Wellness Programs Target BMI. Presented at: Obesity Week;
November 4, 2015; Los Angeles, CA. Available at: http://conscienhealth.org/wp-content/uploads/
2015/11/insurance.pdf
5. American College of Occupational and Environmental Medicine. Methodology for ACOEM's
Occupational Medicine Practice Guidelines - 2017 Revision. 2017. http://www.acoem.org/
uploadedFiles/Knowledge_Centers/Practice_Guidelines/ACOEM%20Practice%20Guidelines
%20Methodology.pdf
6. Harris JS, Weiss MS, Haas NS, et al. Methodology for ACOEM's Occupational Medicine Practice
Guidelines-2017 Revision. J Occup Environ Med. 2017; 59(9):913–9. [PubMed: 28891890]
7. Pelletier K. A review and analysis of the clinical and cost-effectiveness studies of comprehensive
health promotion and disease management programs at the worksite: Update VIII 2008 to 2010. J
Occup Environ Med. 2011; 53(11):1310–31. [PubMed: 22015548]
8. U.S. National Library of Medicine. Health risks of obesity. Medline Plus. 2015. Available at: https://
medlineplus.gov/ency/patientinstructions/000348.htm
9. Jih J, Mukherjea A, Vittinghoff E, et al. Using appropriate body mass index cut points for
overweight and obesity among Asian Americans. Prev Med. 2014:651–6.
10. Burton WN, Chen CY, Schultz AB, Edington DW. The economic costs associated with body mass
index in a workplace. J Occup Environ Med. 1998; 40(9):786–92. [PubMed: 9777562]
11. Wang F, McDonald T, Bender J, Reffitt B, Miller A, Edington DW. Association of healthcare costs
with per unit body mass index increase. J Occup Environ Med. 2006; 48(7):668–74. [PubMed:
16832223]

J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 20

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

12. Van Nuys K, Globe D, Ng-Mak D, Cheung H, Sullivan J, Goldman D. The association between
employee obesity and employer costs: evidence from a panel of U.S. employers. Am J Health
Promot. 2014; 28(5):277–85. [PubMed: 24779722]
13. Henke RM, Carls GS, Short ME, et al. The relationship between health risks and health and
productivity costs among employees at Pepsi Bottling Group. J Occup Environ Med. 2010; 52(5):
519–27. [PubMed: 20431407]
14. Arena VC, Padiyar KR, Burton WN, Schwerha JJ. The impact of body mass index on short-term
disability in the workplace. J Occup Environ Med. 2006; 48(11):1118–24. [PubMed: 17099447]
15. Ostbye T, Dement JM, Krause KM. Obesity and workers' compensation: results from the Duke
Health and Safety Surveillance System. Arch Intern Med. 2007; 167(8):766–73. [PubMed:
17452538]
16. Hertz RP, Unger AN, McDonald M, Lustik MB, Biddulph-Krentar J. The impact of obesity on
work limitations and cardiovascular risk factors in the U.S. workforce. J Occup Environ Med.
2004; 46(12):1196–203. [PubMed: 15591970]
17. National Heart Lung and Blood Institute. Overweight and Obesity. Feb, 2017 Available at: https://
www.nhlbi.nih.gov/health/health-topics/topics/obe/
18. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of
overweight and obesity in adults: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014; 129(25
Suppl 2):S102–38. [PubMed: 24222017]
19. Lau DC, Douketis JD, Morrison KM, et al. 2006 Canadian clinical practice guidelines on the
management and prevention of obesity in adults and children [summary]. CMAJ. 2007;
176(8):S1–13.
20. Yumuk V, Tsigos C, Fried M, et al. European Guidelines for Obesity Management in Adults. Obes
Facts. 2015; 8(6):402–24. [PubMed: 26641646]
21. National Committee for Quality Assurance (NCQA). Healthcare Effectiveness Data and
Information Set (HEDIS). Available at: http://www.ncqa.org/hedis-quality-measurement/hedismeasures#sthash.2euJ65Hj.dpuf
22. Moyer VA. Force USPST. Screening for and management of obesity in adults: U.S. Preventive
Services Task Force recommendation statement. Ann Intern Med. 2012; 157(5):373–8. [PubMed:
22733087]
23. National Heart Lung and Blood Institute. What Is Metabolic Syndrome?. Jun, 2016 Available at:
https://www.nhlbi.nih.gov/health/health-topics/topics/ms
24. National Heart Lung and Blood Institute. Aim for a Healthy Weight. Aug, 2005 Available at:
https://www.nhlbi.nih.gov/files/docs/public/heart/aim_hwt.pdf
25. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim
statement of the International Diabetes Federation Task Force on Epidemiology and Prevention;
National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;
International Atherosclerosis Society; and International Association for the Study of Obesity.
Circulation. 2009; 120(16):1640–5. [PubMed: 19805654]
26. Daniel S, Soleymani T, Garvey WT. A complications-based clinical staging of obesity to guide
treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes. 2013; 20(5):377–88.
[PubMed: 23974764]
27. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and
American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care
of Patients with Obesity. Endocr Pract. 2016; 22(Suppl):31–203.
28. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes (Lond). 2009;
33(3):289–95. [PubMed: 19188927]
29. Kuk JL, Ardern CI, Church TS, et al. Edmonton Obesity Staging System: association with weight
history and mortality risk. Appl Physiol Nutr Metab. 2011; 36(4):570–6. [PubMed: 21838602]
30. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system
to predict mortality in a population-representative cohort of people with overweight and obesity.
CMAJ. 2011; 183(14):E1059–66. [PubMed: 21844111]

J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 21

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

31. Steele, C., Thomas, C., Henley, S., et al. Vital Signs: Trends in incidence of cancers associated with
overweight and obesity - United States, 2005–2014. MMWR Morb Mortal Wkly Rep. Oct 3, 2017.
ePub: DOI: http://dx.doi.org/10.15585/mmwr.mm6639e1
32. Gu JK, Charles LE, Bang KM, et al. Prevalence of obesity by occupation among US workers: the
National Health Interview Survey 2004–2011. J Occup Environ Med. 2014; 56(5):516–28.
[PubMed: 24682108]
33. Centers for Disease Control and Prevention. The Health Effects of Overweight and Obesity. Jun,
2015 Available at: https://www.cdc.gov/healthyweight/effects/index.html
34. National Heart Lung and Blood Institute. Signs, Symptoms, and Complications. Feb, 2017
Available at: https://www.nhlbi.nih.gov/health/health-topics/topics/obe/signs
35. Fried Y, Laurence G, Shirom A, et al. The relationship between job enrichment and abdominal
obesity: a longitudinal field study of apparently healthy individuals. J Occup Health Psychology.
2013; 18(4):458–68.
36. Lyall D, Celis-Morales C, Ward J, et al. Association of Body Mass Index with cardiometabolic
disease in the UK Biobank: A mendelian randomization study. JAMA Cardiol. 2017 Jul 5.doi:
10.1001/jamacardio.2016.5804
37. Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L. The impact of obesity on
the musculoskeletal system. Intl J Obesity. 2008:32211–22.
38. Schoenfisch A, Dement J, Stankevitz K, Ostbye T. The relationship between BMI and work-related
musculoskeletal (MSK) injury rates is modified by job-associated level of MSK injury risk. J
Occup Environ Med. 2017; 59(5):425–33. [PubMed: 28379879]
39. National Heart Lung and Blood Institute. What Is Obesity Hypoventilation Syndrome?. Jan, 2012
Available at: https://www.nhlbi.nih.gov/health/health-topics/topics/ohs
40. Oksanen T, Kawachi I, Subramanian S, et al. Do obesity and sleep problems cluster in the
workplace? A multivariate, multilevel study. Scand J Work Environ Health. 2013; 39(3):276–83.
[PubMed: 23172395]
41. Mokhlesi B. Obesity hypoventilation syndrome: A state-of-the-art review. Respir Care. 2010;
55(10):1347–62. [PubMed: 20875161]
42. Thinkhamrop W, Laohasiriwong W. Factors associated with musculoskeletal disorders among
registered nurses: evidence from the Thai Nurse Cohort Study. Kathmandu Univ Med J. 2015;
51(3):238–43.
43. Puhl R, Heuer C. The stigma of obesity: a review and update. Obesity (Silver Spring). 2009; doi:
10.1038/oby.2008.636
44. Mozaffarian D, Benjamin E, Go A, et al. Heart Disease and Stroke Statistics—2016 Update. A
Report From the American Heart Association. Circulation. 132:000–000. DOI: 10.1161/CIR.
0000000000000350
45. Andreyeva T, Luedicke J, Wang YC. State-level estimates of obesity-attributable costs of
absenteeism. J Occup Environ Med. 2014; 56(11):1120–7. [PubMed: 25376405]
46. Trust for America's Health and Robert Wood Johnson Foundation. The State of Obesity: 2016.
Better Policies for a Healthier America. Sep, 2016 Available at: http://healthyamericans.org/assets/
files/TFAH-2016-ObesityReport-FINAL.pdf
47. Finkelstein EA, Khavjou OA, Thompson H, et al. Obesity and severe obesity forecasts through
2030. Am J Prev Med. 2012; 42(6):563–70. [PubMed: 22608371]
48. Trust for America's Health and Robert Wood Johnson Foundation. F as in Fat: How Obesity
Threatens America's Future - 2011. Washington, DC: Trust for America's Health; 2011.
49. Dong XS, Wang X, Largay JA. Occupational and non-occupational factors associated with workrelated injuries among construction workers in the USA. Int J Occup Environ Health. 2015; 21(2):
142–50. [PubMed: 25816923]
50. Sanchez Bustillos A, Vargas Kr, Gomero-Cuadra R. Work productivity among adults with varied
Body Mass Index: Results from a Canadian population-based survey. J Epidemiol Glob Health.
2015; 5(2):191–9. [PubMed: 25922329]
51. Proper KI, Koppes LL, Meijer S, Bemelmans WJ. The association between body mass index status
and sick leave and the role of emotional exhaustion-a mediation analysis among a representative
sample of dutch employees. J Occup Environ Med. 2013; 55(10):1213–8. [PubMed: 24064779]
J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 22

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

52. Gartoulla P, Bell RJ, Worsley R, Davis SR. Menopausal vasomotor symptoms are associated with
poor self-assessed work ability. Maturitas. 2016:8733–9.
53. Bi Y, Wang L, Xu Y, et al. Diabetes-related metabolic risk factors in internal migrant workers in
China: a national surveillance study. Lancet Diabetes Endocrinol. 2016; 4(2):125–35. [PubMed:
26776861]
54. Kleinert S, Horton R. Rethinking and reframing obesity. Lancet. 2015; 385(9985):2326–8.
[PubMed: 25703115]
55. Pronk NP. Fitness of the US workforce. Annu Rev Public Health. 2015:36131–49.
56. Roos E, Lallukka T, Rahkonen O, Lahelma E, Laaksonen M. Working conditions and major weight
gain-a prospective cohort study. Arch Environ Occup Health. 2013; 68(3):166–72. [PubMed:
23566324]
57. Schulte PA, Wagner GR, Ostry A, et al. Work, obesity, and occupational safety and health. Am J
Public Health. 2007; 97(3):428–36. [PubMed: 17267711]
58. Sorensen G, McLellan DL, Sabbath EL, et al. Integrating worksite health protection and health
promotion: A conceptual model for intervention and research. Prev Med. 2016:91188–96.
59. Framer, E., Kaplan, G., Pronk, N. Chapter 17: Addressing obesity at the workplace. In: O'Donnell,
M., editor. Health Promotion in the Workplace. 4. Troy, MI: American Journal of Health
Promotion Inc; 2014. p. 509-34.
60. Kottwitz MU, Grebner S, Semmer NK, Tschan F, Elfering A. Social stress at work and change in
women's body weight. Ind Health. 2014; 52(2):163–71. [PubMed: 24429516]
61. Nelson CC, Wagner GR, Caban-Martinez AJ, et al. Physical activity and body mass index: the
contribution of age and workplace characteristics. Am J Prev Med. 2014; 46(3 Suppl 1):S42–51.
[PubMed: 24512930]
62. Sorensen G, Stoddard AM, Stoffel S, et al. The role of the work context in multiple wellness
outcomes for hospital patient care workers. J Occup Environ Med. 2011; 53(8):899–910.
[PubMed: 21775897]
63. Pronk NP, Martinson B, Kessler RC, Beck AL, Simon GE, Wang P. The association between work
performance and physical activity, cardiorespiratory fitness, and obesity. J Occup Environ Med.
2004; 46(1):19–25. [PubMed: 14724474]
64. Quist H, Christensen U, Christensen K, Aust B, Borg V, Bjorner J. Psychosocial work environment
factors and weight change: a prospective study among Danish health care workers. BMC Public
Health. 2013; 1343
65. Carayon, P., Lim, S-Y. Chapter 15: Psychosocial Work Factors. In: Karwowski, W., Marras, W.,
editors. The Occupational Ergonomics Handbook. CRC Press LLC; 1999.
66. Luckhaupt SE, Cohen MA, Li J, Calvert GM. Prevalence of obesity among U.S. workers and
associations with occupational factors. Am J Prev Med. 2014; 46(3):237–48. [PubMed: 24512862]
67. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J
Med. 2007; 357(4):370–9. [PubMed: 17652652]
68. Rush T, LeardMann CA, Crum-Cianflone NF. Obesity and associated adverse health outcomes
among US military members and veterans: Findings from the millennium cohort study. Obesity
(Silver Spring). 2016; 24(7):1582–9. [PubMed: 27345964]
69. Buden JC, Dugan AG, Namazi S, Huedo-Medina TB, Cherniack MG, Faghri PD. Work
characteristics as predictors of correctional supervisors' health outcomes. J Occup Environ Med.
2016; 58(9):e325–34. [PubMed: 27483335]
70. Olson R, Thompson S, Wipfli B, et al. Sleep, dietary, and exercise behavioral clusters among truck
drivers with obesity. Implications for interventions. J Occup Environ Med. 2016; 58(3):314–21.
[PubMed: 26949883]
71. Munir F, Clemes S, Houdmont J, Randall R. Overweight and obesity in UK firefighters. Occup
Med (Lond). 2012; 62(5):362–5. [PubMed: 22679213]
72. Mercan MA. A research note on the relationship between long working hours and weight gain for
older workers in the United States. Res Aging. 2014; 36(5):557–67. [PubMed: 25651510]
73. Hauck N, Hollingsworth B. Employment, work hours, and weight gain among middle-aged
women. Int J Obes. 2013; 37:718–24.

J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 23

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

74. Buchvold HV, Pallesen S, Oyane NM, Bjorvatn B. Associations between night work and BMI,
alcohol, smoking, caffeine and exercise--a cross-sectional study. BMC Public Health. 2015;
151112
75. Bekkers MB, Koppes LL, Rodenburg W, van Steeg H, Proper KI. Relationship of night and shift
work with weight change and lifestyle behaviors. J Occup Environ Med. 2015; 57(4):e37–44.
[PubMed: 25749131]
76. Nedeltcheva AV, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD. Sleep curtailment is
accompanied by increased intake of calories from snacks. Am J Clin Nutr. 2009; 89(1):126–33.
[PubMed: 19056602]
77. Shrestha N, Pedisic Z, Neil-Sztramko S, et al. The impact of obesity in the workplace: a review of
contributing factors, consequences and potential solutions. Curr Obes Rep. 2016; 5:344. [PubMed:
27447869]
78. Nabe-Nielsen K, Quist HG, Garde AH, Aust B. Shiftwork and changes in health behaviors. J
Occup Environ Med. 2011; 53(12):1413–7. [PubMed: 22157647]
79. Centers for Disease Control and Prevention. Worker Productivity - Obesity Evaluation Measures.
Apr, 2016 Available at: www.cdc.gov/workplacehealthpromotion/health-strategies/obesity/
evaluation-measures/worker-productivity.html
80. VanWormer J, Linde J, Harnack L, Stovitz S, Jeffery R. Weight change and workplace absenteeism
in the HealthWorks Study. Obes Facts. 2012:5745–52.
81. Harden SM, You W, Almeida FA, et al. Does Successful Weight Loss in an Internet-Based
Worksite Weight Loss Program Improve Employee Presenteeism and Absenteeism? Health Educ
Behav. 2015; 42(6):769–74. [PubMed: 25842385]
82. Cancelliere C, Cassidy J, Ammendolia C, Côté P. Are workplace health promotion programs
effective at improving presenteeism in workers? A systematic review and best evidence synthesis
of the literature. BMC Public Health. 2011; 11395
83. Wing R. Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight
and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the
Look AHEAD trial. Arch Intern Med. 2010; 170(17):1566–75. [PubMed: 20876408]
84. Diabetes Prevention Program Research Group. Reduction in the incidence of Type 2 diabetes with
lifestyle intervention or metformin. N Engl J Med. 2002; 346:393–403. [PubMed: 11832527]
85. Appel LJ, Clark JM, Yeh HC, et al. Comparative effectiveness of weight-loss interventions in
clinical practice. N Engl J Med. 2011; 365(21):1959–68. [PubMed: 22085317]
86. Wadden TA, Volger S, Sarwer DB, et al. A two-year randomized trial of obesity treatment in
primary care practice. N Engl J Med. 2011; 365(21):1969–79. [PubMed: 22082239]
87. Legro RS, Dodson WC, Kris-Etherton PM, et al. Randomized Controlled Trial of Preconception
Interventions in Infertile Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab.
2015; 100(11):4048–58. [PubMed: 26401593]
88. Schippers M, Adam PC, Smolenski DJ, Wong HT, de Wit JB. A meta-analysis of overall effects of
weight loss interventions delivered via mobile phones and effect size differences according to
delivery mode, personal contact, and intervention intensity and duration. Obes Rev. 2017; 18(4):
450–9. [PubMed: 28187246]
89. Knowler W, Fowler S, et al. Diabetes Prevention Program Research Group. 10-year follow-up of
diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet.
2009; 374(9702):1677–86. [PubMed: 19878986]
90. Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an
endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015; 100(2):342–62.
[PubMed: 25590212]
91. Food and Drug Administration. Guidance for Industry Developing Products for Weight
Management. Draft Guidance. 2007. Available at: https://www.fda.gov/downloads/Drugs/
Guidances/ucm071612.pdf
92. Higa K, Ho T, Tercero F, Yunus T, Boone K. Laparoscopic Roux-en-Y gastric bypass:10-year
follow-up. Surg Obes Relat Dis. 2011; 7(4):516–25. [PubMed: 21333610]

J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 24

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

93. Kothari S, Borgert A, Kallies K, Baker M, Grover B. Long-term (>10-year) outcomes after
laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2017; 13(6):972–8. [PubMed:
28223086]
94. Mehaffey J, LaPar D, Clement K, et al. 10-Year Outcomes After Roux-en-Y Gastric Bypass. Ann
Surg. 2016; 264(1):121–6. [PubMed: 26720434]
95. Rubino F, Nathan DM, Eckel RH, et al. Metabolic Surgery in the Treatment Algorithm for Type 2
Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care. 2016; 39(6):
861–77. [PubMed: 27222544]
96. Hutter M, Schirmer B, Jones D, et al. First report from the American College of Surgeons Bariatric
Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness
positioned between the band and the bypass. Ann Surg. 2011; 254(3):410–20. [PubMed:
21865942]
97. Smetana G, Jones D, Wee C. Should this patient have weight loss surgery?: Grand rounds
discussion from Beth Israel Deaconess Medical Center. Ann Intern Med. 2017; 166(11):808–17.
[PubMed: 28586904]
98. Ibrahim A, Thumma J, Dimick J. Reoperation and medicare expenditures after laparoscopic gastric
band surgery. JAMA Surg. 2017; 152(9):835–42. [PubMed: 28514487]
99. Aminian A, Brethauer S, Kirwan J, Kashyap S, Burguera B, Schauer P. How safe is metabolic/
diabetes surgery? Diabetes Obes Metab. 2015; 17(2):198–201. [PubMed: 25352176]
100. Alosco ML, Galioto R, Spitznagel MB, et al. Cognitive function after bariatric surgery: evidence
for improvement 3 years after surgery. Am J Surg. 2014; 207(6):870–6. [PubMed: 24119892]
101. Alosco ML, Spitznagel MB, Strain G, et al. Improved serum leptin and ghrelin following bariatric
surgery predict better postoperative cognitive function. J Clin Neurol. 2015; 11(1):48–56.
[PubMed: 25628737]
102. Galioto R, Alosco ML, Spitznagel MB, et al. Glucose regulation and cognitive function after
bariatric surgery. J Clin Exp Neuropsychol. 2015; 37(4):402–13. [PubMed: 25875124]
103. Hawkins MA, Alosco ML, Spitznagel MB, et al. The association between reduced inflammation
and cognitive gains after bariatric surgery. Psychosom Med. 2015; 77(6):688–96. [PubMed:
25478707]
104. Spitznagel MB, Alosco M, Strain G, et al. Cognitive function predicts 24-month weight loss
success after bariatric surgery. Surg Obes Relat Dis. 2013; 9(5):765–70. [PubMed: 23816443]
105. Longitudinal Assessment of Bariatric Surgery (LABS). Available at: https://
www.niddkrepository.org/studies/labs/
106. Rochette AD, Spitznagel MB, Strain G, et al. Mild cognitive impairment is prevalent in persons
with severe obesity. Obesity (Silver Spring). 2016; 24(7):1427–9. [PubMed: 27227797]
107. Alosco ML, Spitznagel MB, Strain G, et al. Family history of Alzheimer's disease limits
improvement in cognitive function after bariatric surgery. SAGE Open Med. 2014
22050312114539477.
108. Lavender JM, Alosco ML, Spitznagel MB, et al. Association between binge eating disorder and
changes in cognitive functioning following bariatric surgery. J Psychiatr Res. 2014:59148–54.
109. Adams T, Davidson L, Litwin S, et al. Weight and metabolic outcomes 12 Years after gastric
bypass. N Engl J Med. 2017; 377:1143–55. [PubMed: 28930514]
110. Mullen DM, Marr TJ. Longitudinal cost experience for gastric bypass patients. Surg Obes Relat
Dis. 2010; 6(3):243–8. [PubMed: 20510287]
111. Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and
potential cost savings of laparoscopic adjustable gastric banding among obese patients with
diabetes. J Occup Environ Med. 2011; 53(9):1025–9. [PubMed: 21866052]
112. Ewing BT, Thompson MA, Wachtel MS, Frezza EE. A cost-benefit analysis of bariatric surgery
on the South Plains region of Texas. Obes Surg. 2011; 21(5):644–9. [PubMed: 20852965]
113. Gunstad J, Strain G, Devlin MJ, et al. Improved memory function 12 weeks after bariatric
surgery. Surg Obes Relat Dis. 2011; 7(4):465–72. [PubMed: 21145295]
114. King WC, Chen JY, Belle SH, et al. Change in pain and physical function following bariatric
surgery for severe obesity. JAMA. 2016; 315(13):1362–71. [PubMed: 27046364]

J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 25

Author Manuscript
Author Manuscript

115. Kleinman NL, Melkonian A, Borden St, Rohrbacker N, Lynch WD, Gardner HH. The impact of
morbid obesity and bariatric surgery on comorbid conditions: a comprehensive examination of
comorbidities in an employed population. J Occup Environ Med. 2009; 51(2):170–9. [PubMed:
19209038]
116. Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability
of weight loss. JAMA Surg. 2016; 151(11):1046–55. [PubMed: 27579793]
117. Sockalingam S, Wnuk S, Kantarovich K, et al. Employment outcomes one year after bariatric
surgery: the role of patient and psychosocial factors. Obes Surg. 2015; 25(3):514–22. [PubMed:
25248509]
118. Tewksbury C, Williams NN, Dumon KR, Sarwer DB. Preoperative medical weight management
in bariatric surgery: a review and reconsideration. Obes Surg. 2017; 27(1):208–14. [PubMed:
27761723]
119. Voelker R. Deaths reported after intragastric balloon surgery. JAMA. 2017; 318(11):996.doi:
10.1001/jama.2017.12984
120. Ellison JM, Steffen KJ, Sarwer DB. Body contouring after bariatric surgery. Eur Eat Disord Rev.
2015; 23(6):479–87. [PubMed: 26395601]
121. Sarwer DB, Polonsky HM. Body image and body contouring procedures. Aesthet Surg J. 2016;
36(9):1039–47. [PubMed: 27634782]
122. Zheng Y, Manson J, Yuan C, et al. Associations of weight gain from early to middle adulthood
with major health outcomes later in life. JAMA. 2017; 318(3):255–69. [PubMed: 28719691]

Author Manuscript
Author Manuscript
J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

Yarborough et al.

Page 26

Table 1

Author Manuscript

Topical Matrix by Evidence Level for Included Studies
Topic

Evidence Level

Benefits of Addressing Obesity in Workplace

Level 2 – 53

Total Studies
60

Level 2a – 5
Level 2* – 2
Impact of Workplace on Obesity

Level 1 – 1

34

Level 1* – 8
Level 2 – 17
Level 2* – 8
Lifestyle Modification – Behavioral Health

Level 1 – 42

101

Author Manuscript

Level 2 – 58
Level 2a – 1
Lifestyle Modification – Diet/Nutrition

Level 1 – 4

5

Level 2 – 1
Lifestyle Modification – Exercise/Increased Physical Activity

Level 1 – 12

27

Level 2 – 15
Lifestyle Modification – Multiple Modalities

Level 1 – 13

27

Level 2 – 14

Author Manuscript

Problem of Obesity in Workplace

Level 2 – 2

2

Bariatric Surgery

Level 2 – 5

19

Level 2* – 12
Level 2a – 2
Level 1 – Randomized Controlled Trial, Level 2 – prospective cohort studies, prospective comparative studies, and large population-based studies,
Level 2a – prospective simulation studies.

*

Occurred in laboratory rather than real workplace setting.

Author Manuscript
J Occup Environ Med. Author manuscript; available in PMC 2018 July 06.

